| Lastest Insider Transactions Of Nurix Therapeutics, Inc. ( NRIX ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-04 | Sell | 3,290 | 25.00 | 82,250 | 2024-11-04 17:48:03 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-04 | Option Exercise | 3,290 | 9.57 | 31,485 | 2024-11-04 17:48:03 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-01 | Sell | 5,760 | 24.28 | 139,867 | 2024-11-01 17:57:23 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-01 | Option Exercise | 5,760 | 1.86 | 10,714 | 2024-11-01 17:57:23 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-11-01 | Sell | 3,546 | 24.28 | 86,083 | 2024-11-01 17:57:13 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-10-30 | Sell | 2,368 | 24.30 | 57,554 | 2024-10-30 20:30:27 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-10-30 | Option Exercise | 8,636 | 0.00 | 0 | 2024-10-30 20:30:27 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-10-30 | Sell | 3,437 | 24.30 | 83,536 | 2024-10-30 20:30:17 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-10-30 | Option Exercise | 8,957 | 0.00 | 0 | 2024-10-30 20:30:17 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-30 | Option Exercise | 7,674 | 0.00 | 0 | 2024-10-30 20:30:07 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-30 | Sell | 4,182 | 24.30 | 101,644 | 2024-10-30 20:30:07 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-14 | Sell | 3,290 | 25.00 | 82,250 | 2024-10-15 09:16:24 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-14 | Option Exercise | 3,290 | 9.57 | 31,485 | 2024-10-15 09:16:24 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-01 | Sell | 5,760 | 22.23 | 128,017 | 2024-10-01 19:36:27 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-01 | Option Exercise | 5,760 | 1.86 | 10,714 | 2024-10-01 19:36:27 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-08-26 | Sell | 9,870 | 25.01 | 246,843 | 2024-08-26 18:23:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-08-26 | Option Exercise | 9,870 | 6.08 | 60,046 | 2024-08-26 18:23:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-07-01 | Sell | 5,760 | 20.81 | 119,837 | 2024-07-01 18:35:21 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-07-01 | Option Exercise | 5,760 | 1.86 | 10,714 | 2024-07-01 18:35:21 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-06-20 | Sell | 20,000 | 20.01 | 400,216 | 2024-06-20 16:58:20 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-13 | Sell | 1,864 | 17.02 | 31,721 | 2024-06-13 18:39:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-13 | Option Exercise | 1,864 | 1.86 | 3,467 | 2024-06-13 18:39:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-12 | Sell | 1,900 | 17.01 | 32,319 | 2024-06-12 19:30:50 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-12 | Option Exercise | 1,900 | 1.86 | 3,534 | 2024-06-12 19:30:50 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-05 | Sell | 400 | 17.00 | 6,801 | 2024-06-05 18:01:04 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-05 | Option Exercise | 400 | 1.86 | 744 | 2024-06-05 18:01:04 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-03 | Sell | 1,596 | 17.01 | 27,153 | 2024-06-03 18:36:17 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-03 | Option Exercise | 1,596 | 1.86 | 2,969 | 2024-06-03 18:36:17 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-05-02 | Sell | 3,499 | 12.83 | 44,878 | 2024-05-02 18:01:27 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-04-30 | Sell | 1,387 | 12.04 | 16,703 | 2024-04-30 18:33:33 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-04-30 | Option Exercise | 4,886 | 0.00 | 0 | 2024-04-30 18:33:33 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-04-30 | Sell | 2,007 | 12.04 | 24,169 | 2024-04-30 18:33:20 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-04-30 | Option Exercise | 5,206 | 0.00 | 0 | 2024-04-30 18:33:20 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-04-30 | Sell | 1,513 | 12.04 | 18,220 | 2024-04-30 18:33:06 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-04-30 | Option Exercise | 3,924 | 0.00 | 0 | 2024-04-30 18:33:06 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-02-16 | Sell | 6,812 | 10.02 | 68,223 | 2024-02-16 19:20:25 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-01-30 | Sell | 1,671 | 7.99 | 13,352 | 2024-01-30 18:53:11 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-01-30 | Option Exercise | 4,886 | 0.00 | 0 | 2024-01-30 18:53:11 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-01-30 | Sell | 2,334 | 7.99 | 18,649 | 2024-01-30 18:52:58 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-01-30 | Option Exercise | 5,207 | 0.00 | 0 | 2024-01-30 18:52:58 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-01-30 | Sell | 1,760 | 7.99 | 14,063 | 2024-01-30 18:52:46 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-01-30 | Option Exercise | 3,924 | 0.00 | 0 | 2024-01-30 18:52:46 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-12-20 | Sell | 3,541 | 10.00 | 35,421 | 2023-12-21 17:19:53 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-12-19 | Sell | 10,906 | 10.00 | 109,093 | 2023-12-20 16:55:24 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-10-30 | Sell | 1,080 | 5.20 | 5,613 | 2023-11-01 16:41:06 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-10-30 | Option Exercise | 4,886 | 0.00 | 0 | 2023-11-01 16:41:06 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2023-10-30 | Sell | 1,232 | 5.20 | 6,403 | 2023-11-01 16:40:52 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2023-10-30 | Option Exercise | 3,924 | 0.00 | 0 | 2023-11-01 16:40:52 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-10-30 | Sell | 1,633 | 5.20 | 8,487 | 2023-11-01 16:40:40 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-10-30 | Option Exercise | 5,207 | 0.00 | 0 | 2023-11-01 16:40:40 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-07-30 | Sell | 1,245 | 9.65 | 12,020 | 2023-08-01 16:28:39 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-07-30 | Option Exercise | 4,886 | 0.00 | 0 | 2023-08-01 16:28:39 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-07-30 | Sell | 1,420 | 9.65 | 13,710 | 2023-08-01 16:27:49 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-07-30 | Option Exercise | 3,924 | 0.00 | 0 | 2023-08-01 16:27:49 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-07-30 | Sell | 1,884 | 9.65 | 18,189 | 2023-08-01 16:26:17 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-07-30 | Option Exercise | 5,207 | 0.00 | 0 | 2023-08-01 16:26:17 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-04-30 | Sell | 342 | 9.88 | 3,378 | 2023-05-02 16:33:54 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-04-30 | Option Exercise | 962 | 0.00 | 0 | 2023-05-02 16:33:54 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-04-30 | Sell | 721 | 9.88 | 7,121 | 2023-05-02 16:33:07 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-04-30 | Option Exercise | 2,886 | 0.00 | 0 | 2023-05-02 16:33:07 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-04-30 | Sell | 682 | 9.88 | 6,736 | 2023-05-02 16:32:08 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-04-30 | Option Exercise | 1,924 | 0.00 | 0 | 2023-05-02 16:32:08 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-04-30 | Sell | 1,136 | 9.88 | 11,219 | 2023-05-02 16:31:19 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-04-30 | Option Exercise | 3,206 | 0.00 | 0 | 2023-05-02 16:31:19 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-01-30 | Sell | 424 | 11.78 | 4,995 | 2023-02-01 16:18:42 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-01-30 | Option Exercise | 962 | 0.00 | 0 | 2023-02-01 16:18:42 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-01-30 | Sell | 924 | 11.78 | 10,884 | 2023-02-01 16:17:47 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-01-30 | Option Exercise | 2,886 | 0.00 | 0 | 2023-02-01 16:17:47 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-01-30 | Sell | 848 | 11.78 | 9,989 | 2023-02-01 16:16:46 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-01-30 | Option Exercise | 1,924 | 0.00 | 0 | 2023-02-01 16:16:46 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-01-30 | Sell | 1,412 | 11.78 | 16,633 | 2023-02-01 16:15:51 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-01-30 | Option Exercise | 3,207 | 0.00 | 0 | 2023-02-01 16:15:51 |
